Cargando…
Effects of Oral L-Carnitine Administration in Narcolepsy Patients: A Randomized, Double-Blind, Cross-Over and Placebo-Controlled Trial
Narcolepsy is a sleep disorder characterized by excessive daytime sleepiness, cataplexy, and rapid eye movement (REM) sleep abnormalities. A genome-wide association study (GWAS) identified a novel narcolepsy-related single nucleotide polymorphism (SNP), which is located adjacent to the carnitine pal...
Autores principales: | Miyagawa, Taku, Kawamura, Hiromi, Obuchi, Mariko, Ikesaki, Asuka, Ozaki, Akiko, Tokunaga, Katsushi, Inoue, Yuichi, Honda, Makoto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547955/ https://www.ncbi.nlm.nih.gov/pubmed/23349733 http://dx.doi.org/10.1371/journal.pone.0053707 |
Ejemplares similares
-
Genetics of narcolepsy
por: Miyagawa, Taku, et al.
Publicado: (2019) -
Narcolepsy susceptibility gene CCR3 modulates sleep-wake patterns in mice
por: Toyoda, Hiromi, et al.
Publicado: (2017) -
Narcolepsy type I-associated DNA methylation and gene expression changes in the human leukocyte antigen region
por: Yoshida-Tanaka, Kugui, et al.
Publicado: (2023) -
Optimal dose determination of enerisant (TS-091) for patients with narcolepsy: two randomized, double-blind, placebo-controlled trials
por: Inoue, Yuichi, et al.
Publicado: (2022) -
Polymorphism Located between CPT1B and CHKB, and HLA-DRB1*1501-DQB1*0602 Haplotype Confer Susceptibility to CNS Hypersomnias (Essential Hypersomnia)
por: Miyagawa, Taku, et al.
Publicado: (2009)